Comprehensive Textbook of Genitourinary Oncology

by Vogelzang, Nicholas J.; Scardino, Peter T.; Shipley, William U.; Debruyne, Frans M.J.; Linehan, W. Marston

• ISBN13: 9780781749848
• ISBN10: 0781749840
• Edition: 3rd
• Format: Hardcover
• Copyright: 2005-09-15
• Publisher: LWW

Summary

Thoroughly revised for its Third Edition, this volume is the most comprehensive, multidisciplinary text on genitourinary cancers. This edition has two new editors--Frans M.J. Debruyne and W. Marston Linehan--and more than 50% new contributors. Seventeen new chapters cover familial prostate cancer, biology of bone metastases, molecular pathology and biologic determinants, PSA and related kallikreins, needle biopsy, laparoscopic surgical procedures, 3D conformal radiotherapy, hormones and radiotherapy, integration of chemotherapy and other modalities, quality of life after treatment of localized prostate cancer, management of rising PSA after local therapy, the role of surgery in advanced bladder cancer, post-chemotherapy node dissections and resection of metastatic disease, and stem cell transplantation.

Table of Contents

Contributing Authors	xiii
Preface to the Third Edition	xxv
Preface to the First Edition	xxvii
Acknowledgments	xxix
PART I PROSTATE CANCER
Clinical Presentation of Prostate Cancer in the 21st Century: Where have all the Signs and Symptoms Gone?	1	(8)
John W. Davis
Paul F. Schellhammer
Epidemiology of Prostate Cancer	9	(14)
Edward Giovannucci
Elizabeth A. Platz
Familial Prostate Cancer	23	(8)
William B. Isaacs
Jianfeng Xu
The Role of the Androgen Receptor in the Pathophysiology of Prostate Cancer	31	(8)
Zoran Culig
Jose D. Debes
Georg Bartsch
Donald J. Tindall
Biology of Bone Metastases in Men with Prostate Cancer	39	(6)
Matthew R. Smith
Anatomy and Pathology of Prostate Cancer	45	(34)
Anatomy of the Prostate and the Pathology of Prostate Cancer	45	(15)
Gustavo Ayala
Thomas M. Wheeler
Prostate Cancer: Molecular Pathology and Biologic Determinants	60	(19)
Mark A. Rubin
Massimo Loda
Prevention of Prostate Cancer	79	(8)
Javier Hernandez
Ian M. Thompson Jr.
Screening and Early Detection	87	(24)
Screening and Early Detection of Prostate Cancer: Prostate Specific Antigen and Related Kallikreins	87	(15)
Thomas Steuber
Kevin M. Slawin
Hans Lilja
Screening for Prostate Cancer	102	(4)
Freddie C. Hamdy
Jenny L. Donovan
David E. Neal
Screening for Prostate Cancer: Experience from the Tyrol Study	106	(5)
Wolfgang Horninger
Peter Boyle
Georg Bartsch
Prostate Needle Biopsy Techniques and Interpretation	111	(10)
Katsuto Shinohara
Viraj A. Master
Thomas Chi
Peter R. Carroll
Staging Systems for Prostate Cancer	121	(8)
David C. Miller
James E. Montie
The Utility of Outcome Prediction Models for Prostate Cancer Therapy	129	(8)
Andrew J. Stephenson
Michael W. Kattan
Imaging in Prostate Cancer	137	(16)
Michael Mullerad
Amita Shukla-Dave
Hedvig Hricak
Treatment of Early Stage Prostate Cancer	153	(86)
Advising Patients with Early Prostatic Cancer on Their Treatment Decision	153	(4)
William U. Shipley
Peter T. Scardino
Donald S. Kaufman
Michael W. Kattan
Active Surveillance for ``Good-Risk'' Prostate Cancer: Rationale, Method, and Results	157	(9)
Arthur C. Grabowski
Laurence Klotz
Radical Prostatectomy for Clinical Stage T1 and T2 Prostate Cancer	166	(23)
James A. Eastham
Peter T. Scardino
Laparoscopic Radical Prostatectomy	189	(10)
Karim A. Touijer
Bertrand D. Guillonneau
Robot-assisted Radical Prostatectomy	199	(4)
Peter N. Wiklund
Stefan Carllson
3D Conformal Radiotherapy for Localized Prostate Cancer	203	(14)
Howard M. Sandler
Jeff Michalski
Intensity Modulated Radiotherapy and Proton Beam Therapy for the Treatment of Prostate Cancer	217	(7)
Steven A. Leibel
Zvi Fuks
Anthony Zietman
Brachytherapy	224	(15)
Michael J. Zelefsky
W. Robert Lee
Management of High Risk Prostate Cancer	239	(38)
Combined Hormone Therapy and Modern Radiation Therapy for High-Risk Prostate Cancer	239	(7)
Michel Bolla
Mack Roach, III
Surgical Management of Clinical T3 (cT3) and Node Positive (pN +) Adenocarcinoma of the Prostate	246	(8)
Gregory S. Schenk
Michael L. Blute
Horst Zincke
The Role of Hormonal Therapy Combined with Surgery in the Management of Prostate Cancer	254	(9)
Alan So
S. Larry Goldenberg
Integrating Chemotherapy into Multidisciplinary Treatments for Prostate Cancer	263	(4)
Kenneth J. Pienta
Quality of Life after Treatment for Localized Prostate Cancer	267	(10)
Mark S. Litwin
Arnold L. Potosky
Treatment of Locally Recurrent Prostate Cancer	277	(38)
Definition of Failure Recurrence after Primary Therapy---Radical Prostatectomy and Radiation Therapy	277	(8)
Christopher L. Amling
Anthony Zietman
Management of Rising Prostate-specific Antigen Following Surgery or Radiation Therapy	285	(2)
Anthony V. D'Amico
Management of Rising Prostate-specific Antigen after Local Surgical Therapy	287	(8)
J. Kellogg Parsons
Alan W. Partin
Adjuvant and Salvage Radiotherapy, Postprostatectomy	295	(11)
Alan Pollack
Salvage Radical Prostatectomy for Recurrence of Prostate Cancer after Radiation Therapy	306	(9)
James A. Eastham
Peter T. Scardino
Advanced Prostate Cancer	315	(40)
Initial Management of Metastatic Prostate Cancer	315	(15)
Paul D. Maroni
J. Brantley Thrasher
E. David Crawford
Beyond First-Line Hormones: Options for Treatment of Castration-resistant Disease	330	(11)
Kathleen Beekman
Wayne D. Tilley
Grant Buchanan
Howard I. Scher
Management of Hormone Refractory Prostate Cancer	341	(14)
Miah-Hiang Tay
Mari Nakabayashi
William K. Oh
PART II BLADDER AND UPPER TRACT CANCER
Clinical Signs and Symptoms of Bladder Cancer	355	(2)
Niall M. Heney
The Epidemiology of Bladder Cancer	357	(8)
Ronald K. Ross
Mimi C. Yu
Jian-Min Yuan
Cytology and Pathology of Carcinomas of the Urinary Tract	365	(20)
Robert H. Young
Grace T. McKee
Molecular Biology and Prognostic Markers in Bladder Cancer	385	(18)
Richard J. Cote
Seth P. Lerner
Ram H. Datar
Screening, Early Detection, and Prevention of Bladder Cancer	403	(8)
Jordan R. Steinberg
Colin P. N. Dinney
H. Barton Grossman
Bladder Cancer Staging	411	(6)
Theresa M. Koppie
Bernard H. Bochner
Imaging of Transitional Cell Carcinoma	417	(18)
Alexander R. Guimaraes
Mukesh G. Harisinghani
Upper Tract Tumors	435	(14)
Management of Upper Tract Tumors	435	(7)
R. Houston Thompson
Bradley C. Leibovich
Laparoscopic Management of Upper Tract Tumors	442	(7)
Erik S. Weise
Howard N. Winfield
Risk Assessment and Treatment of Superficial Bladder Cancer	449	(18)
Natural History and Initial Management Based on Prognostic Factors	449	(3)
J.A. Witjes
Frans M.J. Debruyne
Intravesical Therapy	452	(15)
Guido Dalbagni
Michael O'Donnell
Invasive Bladder Cancer	467	(34)
Role of Radical Cystectomy in Patients with Advanced Bladder Cancer	467	(7)
Harry W. Herr
S. Machele Donat
Selective Bladder Preservation in the Treatment of Muscle-invasive Bladder Cancer	474	(12)
Donald S. Kaufman
Anthony L. Zietman
William U. Shipley
Radical Cystectomy	486	(15)
John Peter Stein
Donald G. Skinner
Role of the Lymphadenectomy in Bladder Cancer	501	(6)
Bernard H. Bochner
Urinary Diversions and Reconstructions and Orthotopic Bladder Substitution	507	(20)
Urinary Diversions and Reconstructions	507	(10)
Edward M. Gong
Gary D. Steinberg
Orthotopic Bladder Substitution	517	(10)
Richard E. Hautmann
Neoadjuvant and Adjuvant Chemotherapy in Muscle-Invasive Bladder Cancer	527	(6)
Cora N. Sternberg
Chemotherapy for Metastatic Bladder, Alone or in Combination with Other Treatment	533	(10)
Matthew D. Galsky
Dean F. Bajorin
PART III TESTIS CANCER
Testis Cancer: Clinical Signs and Symptoms	543	(4)
Stephen D. W. Beck
John P. Donohue
Epidemiology of Testis Cancer	547	(16)
Epidemiology of Testis Cancer: A Clinical Perspective	547	(11)
R. T. D. Oliver
Hereditary Testicular Cancer	558	(5)
Joan L. Kramer
Mark H. Greene
Biology and Genetics of Adult Male Germ Cell Tumors	563	(10)
Jane Houldsworth
George J. Bosl
R. S. K. Chaganti
Anatomy and Pathology of Testis Cancer	573	(14)
Victor E. Reuter
Staging and Imaging of Testis Cancer	587	(10)
Graeme S. Steele
Philip Kantoff
Jerome P. Richie
Surveillance for Low-Stage Testicular Germ Cell Cancers	597	(8)
Alan Horwich
Surgical Management	605	(20)
Radical Orchiectomy and Retroperitoneal Lymph Node Dissection	605	(5)
Richard Foster
Richard Bihrle
John P. Donahue
Laparoscopic Retroperitoneal Lymph Node Dissection	610	(6)
Nasser M. Albqami
Gunter Janetschek
Postchemotherapy Retroperitoneal Lymph Node Dissection and Resection or Residual Masses for Germ Cell Tumors of the Testis	616	(9)
Joel Sheinfeld
Role of Chemotherapy for Low-Stage Testis Cancer	625	(4)
Stephane Culine
Radiation Therapy for Testicular Seminoma	629	(10)
Padraig R. Warde
Stephen R. Smalley
Risk-Adapted Therapy of Metastatic Testis Cancer	639	(16)
Risk-Adapted Therapy of Metastatic Testis Cancer: Good-Risk Patients	639	(6)
Stefan Sleijfer
Ronald de Wit
Management and Treatment of Poor Prognosis and Relapsed Germ Cell Tumors	645	(10)
Gnanamba Varuni Kondagunta
George J. Bosl
Robert J. Motzer
Chronic Toxicity from Chemotherapy for Disseminated Testicular Cancer	655	(6)
Timothy David Gilligan
PART IV KIDNEY CANCER
Signs, Symptoms, and Paraneoplastic Syndromes of Renal Cell Carcinoma	661	(8)
Hyung L. Kim
John S. Lam
Arie S. Belldegrun
Epidemiology of Renal Cell Carcinoma	669	(12)
Wong-Ho Chow
Susan S. Devesa
Lee E. Moore
Pathology of Renal Cell Carcinoma	681	(20)
Renal Cancer Pathology and Prognostic Factors	681	(16)
Victor E. Reuter
Paul Russo
Robert J. Motzer
Pathology of Inherited Forms of Renal Carcinoma	697	(4)
Maria J. Merino
Carlos A. Torres-Cabala
Genetic Basis of Kidney Cancer	701	(8)
W. Marston Linehan
Jonathan A. Coleman
McClellan M. Walther
Berton Zbar
Radiologic Imaging of Renal Cell Carcinoma: Its Role in Diagnosis	709	(16)
Peter L. Choyke
Surgical Management of Localized Renal Cell Carcinoma	725	(42)
Open Radical Nephrectomy for Localized Renal Cell Carcinoma	725	(6)
Paul Russo
Laparoscopic Radical Nephrectomy	731	(8)
Isaac Yi Kim
Ralph V. Clayman
Surgical Management of Renal Cell Carcinoma: Role of Lymphadenectomy in Renal Cell Carcinoma Surgery	739	(5)
Hyung L. Kim
John S. Lam
Arie S. Belldegrun
Open Nephron-Sparing Surgery for Renal Cell Carcinoma	744	(6)
Andrew C. Novick
Management of Inherited Forms of Renal Cancer	750	(5)
Robert L. Grubb III
W. Marston Linehan
McClellan M. Walther
Management of Localized Renal Cell Carcinoma: Minimally Invasive Nephron-Sparing Treatment Options	755	(12)
Sidney C. Abreu
Antonio Finelli
Inderbir S. Gill
Management of Metastatic Renal Cell Carcinoma	767	(38)
Management of Metastatic Renal Cell Carcinoma: The Role of Surgery	767	(6)
Robert C. Flanigan
Bradley G. Orris
Management of Metastatic Renal Cell Carcinoma: Interleukin-2	773	(7)
David F. McDermott
Micheal B. Atkins
Cytokines	780	(9)
Thomas E. Hutson
Ronald M. Bukowski
Allogeneic Stem Cell Transplantation for Renal Cell Carcinoma	789	(7)
Andrew Artz
Richard W. Childs
Chemotherapy and Other Approaches in the Management of Metastatic Renal Cell Carcinoma	796	(9)
Walter M. Stadler
PART V PENILE CANCER
Penile Cancer: Clinical Signs and Symptoms	805	(4)
Shahin Tabatabaei
W. Scott McDougal
Surgical Management of Penile Cancer	809	(10)
Paul Russo
Simon Horenblas
Radiation Therapy for Penile Cancer	819	(8)
Juanita M. Crook
Chemotherapy for Penile Cancer	827	(6)
Giorgio Pizzocaro
Winston W. Tan
Robert Dreicer
PART VI OTHER UROLOGIC MALIGNANCIES
Adrenal Neoplasms	833	(26)
Sareena Malhi
Alireza Moinzadeh
Inderbir S. Gill
Ronald M. Bukowski
Genitourinary Sarcomas and Carcinosarcomas in Adults	859	(18)
Tohru Nakagawa
Igor Frank
Satoru Takahashi
Taiji Tsukamoto
Michael M. Lieber
Malignant Lymphoma of the Genitourinary Tract	877	(6)
Ann S. La Casce
M. Dror Michaelson
George P. Canellos
Cancer of the Urethra	883	(10)
Anthony H. Russell
Guido Dalbagni
Urachal Tumors	893	(6)
S. Machele Donat
Harry W. Herr
Index	899